CAPECITABINE

Formula & Concentration

CAPECITABINE – capecitabine 150 mg and 500 mg tablet

Manufacturer

Camber Pharmaceuticals

Indications

HER2+ adenocarcinoma of gastroesophageal junction; metastatic HER2-positive carcinoma of breast; malignant esophageal neoplasm; malignant neoplasm of the ovary; adenocarcinoma of pancreas; pancreatic neuroendocrine tumor; gastric cancer; metastatic colorectal cancer; malignancy; adjuvant treatment of biliary tract carcinoma; lymph node positive colorectal carcinoma; metastatic breast carcinoma

adenocarcinoma of pancreas; HER2+ adenocarcinoma of gastroesophageal junction; malignant esophageal neoplasm; metastatic colorectal cancer; malignant neoplasm of the ovary; metastatic HER2-positive carcinoma of breast; malignancy; pancreatic neuroendocrine tumor; lymph node positive colorectal carcinoma; adjuvant treatment of biliary tract carcinoma; metastatic breast carcinoma; gastric cancer

Product Options

Package Size

NDC #

Presentation

150 MG

31722-0774-60

TABLET

500 MG

31722-0775-12

TABLET

Shelf Life and Storage

Controlled Room Temp (20-25°C)